Joisson et al., 1993 - Google Patents
Antigenic analysis of bean pod mottle virus using linear and cyclized synthetic peptidesJoisson et al., 1993
- Document ID
- 13375981987224066724
- Author
- Joisson C
- Kuster F
- Plaué S
- Van Regenmortel M
- Publication year
- Publication venue
- Archives of virology
External Links
Snippet
The antigenic structure of the comovirus bean pod mottle virus (BPMV) was studied using synthetic peptides selected on the basis of the exposed location of certain regions of the viral protein. Three regions of domain A, four regions of domain B and two regions of domain …
- 102000004196 processed proteins & peptides 0 title abstract description 122
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Trifilieff et al. | Antigenic cross-reactivity potential of synthetic peptides immobilized on polyethylene rods | |
| SK7602001A3 (en) | Hbv core antigen particles with multiple immunogenic components attached via peptide ligands | |
| JPS60500673A (en) | Amino acid sequence with antigenic activity | |
| Daniel et al. | Mapping of linear antigenic sites on the S glycoprotein of a neurotropic murine coronavirus with synthetic peptides: a combination of nine prediction algorithms fails to identify relevant epitopes and peptide immunogenicity is drastically influenced by the nature of the protein carrier | |
| JPH0769924A (en) | Vaccine composition for herpes simplex virus infective disease | |
| CA2033202A1 (en) | Synthetic peptides for diagnosis and prevention of influenza virus infection and their use | |
| PT1881064E (en) | Hcv-anti-core monoclonal antibody | |
| Posthumus et al. | Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus | |
| JP2004525613A (en) | Hepatitis E virus polypeptide fragments, vaccine compositions and diagnostic kits containing the same, and uses thereof | |
| Joisson et al. | Antigenic analysis of bean pod mottle virus using linear and cyclized synthetic peptides | |
| US20060263765A1 (en) | Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars) | |
| JP2818755B2 (en) | Novel branched hybrid and cluster peptides useful for diagnosis and detection of non-A non-B hepatitis | |
| JPH02503916A (en) | Synthetic peptides related to HIV envelope proteins | |
| Bergmann et al. | Hepatitis delta antigen. Antigenic structure and humoral immune response. | |
| CA2144882A1 (en) | Synthetic peptide vaccine for chlamydia trachomatis | |
| JP4593780B2 (en) | Mimotope of hypervariable part 1 of HCV E2 glycoprotein and use thereof | |
| JPH01224397A (en) | Synthetic peptide for detecting hiv antibody and mixture thereof | |
| Mattioli et al. | Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries | |
| JP3317967B2 (en) | Rubella E1 peptide | |
| Irving et al. | Exploring peptide mimics for the production of antibodies against discontinuous protein epitopes | |
| Joisson et al. | Detection of potyviruses with antisera to synthetic peptides | |
| JPH05508838A (en) | Peptides and analogs and mixtures thereof for detecting antibodies to HTLV-I and HTLV-II viruses - Patents.com | |
| JP2000514643A (en) | Antigenic epitope of a-determinant of hepatitis B surface antigen and its use | |
| WO1991006562A1 (en) | Immunological domains of hepatitis delta virus antigen | |
| Dyrberg et al. | Immunological cross-reactivity between mimicking epitopes on a virus protein and a human autoantigen depends on a single amino acid residue |